guanfacine hydrochloride extended-release

Details

Files

Generic Name:

guanfacine hydrochloride extended-release

Project Status:

Pending

Therapeutic Area:

Attention Deficit Hyperactivity Disorder (ADHD)

Manufacturer:

N/A

Call for patient/clinician input open:

March 13, 2025

Brand Name:

N/A

Project Line:

Reimbursement Review

Project Number:

SX0755-000

Call for patient/clinician input closed:

May 6, 2025

Biosimilar:

No

Submission Type:

Non-sponsored Submission

Fee Schedule:

Pending

Indications:

Attention Deficit Hyperactivity Disorder (ADHD)

Files

Proposed Scope View PDF

Last Updated : March 13, 2025